학술논문
Treatment of older patients with mantle-cell lymphoma
Document Type
Clinical report
Author
Kluin-Nelemans, H.C.; Geisler, C.H.; Coiffier, B.; Lepeu, G.; Macro, M.; Hoster, E.; Stilgenbauer, S; Forstpointer, R.; Kremers, S.; Pfreundschuh, M.; Hermine, O.; Thieblemont, C.; Tilly, H.; Kanz, L.; Sanhes, L.; Prochazka, V.; Walewski, J.; Vehling-Kaiser, U.; Feugier, P.; Zijlstra, J.M.; Di Raimondo, F.; Doorduijn, J.K.; Szymczyk, M.; Bouabdallah, R.; Ribrag, V.; Dreyling, M.H.; Hallek, M.; Lugtenburg, P.J.; Uppenkamp, M.; Unterhalt, M.; Klapper, W.; Andre, M.; Hiddemann, W.; Trnemy, M.
Source
The New England Journal of Medicine. August 9, 2012, Vol. 367 Issue 6, p520, 42 p.
Subject
Language
English
ISSN
0028-4793
Abstract
Several studies are conducted for examining the use of a fludarabine-containing induction regimen for the treatment of older patients suffering from mantle-cell lymphoma. The use of maintenance therapy post treatment is shown to be extremely effective for such patients.